Daniel Bradbury

Daniel Bradbury

Founder presso EQUILLIUM, INC.

Patrimonio netto: 9 M $ in data 29/02/2024

62 anni
Health Technology
Commercial Services
Finance

Profilo

Founder of Equillium, Inc., BioBrit LLC and Sensulin LLC, Daniel Mark Bradbury is an American entrepreneur and businessperson who has been the head of 11 different companies and currently occupies the position of Chairman at Castle Biosciences, Inc., Chairman of Sensulin LLC, Chairman at ADCY5 Org, Chairman of Persephone Biosciences, Inc., Executive Chairman at Equillium, Inc. and Chairman for Liquidgrids, Inc. Mr. Bradbury is also Member of Royal Pharmaceutical Society of Great Britain and Managing Member at BioBrit LLC and on the board of 16 other companies.
He previously was Chairman at Thesan Pharmaceuticals, Inc., Chairman of DiaVacs, Inc., Chairman for NeuroVia, Inc., Chairman of Freedom Meditech, Inc., President, Chief Executive Officer & Director at Amylin Pharmaceuticals, Inc. and Principal at Smithkline Beecham Pharmaceuticals (India) Ltd.
He received an undergraduate degree from The University of Nottingham.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
02/01/2024 3 711 995 ( 16.90% ) 9 M $ 29/02/2024
01/12/2023 4 655 ( 0.02% ) 84 069 $ 29/02/2024
04/03/2024 0 ( -.--% ) - $ 29/02/2024

Posizioni attive di Daniel Bradbury

SocietàPosizioneInizio
CASTLE BIOSCIENCES, INC. Chairman 01/09/2014
EQUILLIUM, INC. Founder 16/03/2017
ALTHEADX INC Director/Board Member 01/01/2020
VIVANI MEDICAL, INC. Director/Board Member 04/03/2024
Director/Board Member 18/11/2014
Director/Board Member -
The Riecken Foundation Director/Board Member -
Founder -
Chairman -
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tutte le posizioni attive di Daniel Bradbury

Precedenti posizioni note di Daniel Bradbury

SocietàPosizioneFine
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Daniel Bradbury

Formazione di Daniel Bradbury

The University of Nottingham Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Daniel Bradbury

Relazioni

100 +

Relazioni di 1° grado

45

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa9
GERON CORPORATION

Health Technology

ILLUMINA, INC.

Health Technology

CORCEPT THERAPEUTICS INCORPORATED

Health Technology

INTERCEPT PHARMACEUTICALS, INC.

Health Technology

CASTLE BIOSCIENCES, INC.

Health Technology

BIOCON LIMITED

Health Technology

SYNGENE INTERNATIONAL LIMITED

Commercial Services

EQUILLIUM, INC.

Health Technology

VIVANI MEDICAL, INC.

Health Technology

Aziende private34

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Commercial Services

Smithkline Beecham Pharmaceuticals (India) Ltd.

Health Technology

Health Technology

Commercial Services

Commercial Services

The Riecken Foundation

Health Technology

Health Technology

Health Technology

Finance

Troia Therapeutics, Inc.

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Commercial Services

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Daniel Bradbury